Privacy by Design

Crossix technology was purpose-built
to protect privacy.

To effectively activate and measure marketing campaigns, brands need actionable data and insights. And the best – and most secure – data lives right at the source. Crossix SafeMine™ technology allows matching and analytics within the data supplier environments in our network, using a distributed approach to combine unlimited amounts of information, all while maintaining the highest levels of privacy and security.

The Future of Audience Targeting for Health Brands

Listen to Lauren Dubick, Director, US Data Council at Novartis, and Anthony
Matyjaszewski, Vice President, Compliance and Membership at the NAI,
discuss privacy-safe audience targeting for health brands.

Watch Webinar

Data and Privacy:
What Health Marketers Need to Know

Today’s headlines are filled with stories about data security and consumer privacy. At Crossix, we believe all marketers – both brands and agencies – should make patient privacy a priority when making media and marketing decisions.

How Distributed Analytics Protects Consumer Privacy

A distributed data network is one in which no central repository of data exists. With no centralized “de-identified” data asset, Crossix SafeMine™ enables breakthrough connections across various historically siloed datasets while eliminating many of the re-identification and data security risks inherent with other, legacy approaches.

Instead, analytics take place within the data centers in our network, behind privacy firewalls. Our technology can perform analytics, including machine learning, based on actual health data.

Today, our solutions span the marketing cycle from segmentation to targeting to measurement, but our commitment to patient privacy remains at the core of what we do.

  • No employee at Crossix can access any personally identifiable information (PII), device identifiable information (DII) or protected health information (PHI).
  • Only HIPAA-certified de-identified results leave the health data suppliers and arrive at Crossix for use in aggregated analytics.

Privacy In-Depth:
How Today’s Headlines Will Impact Your Business

Beyond HIPAA: Re-identification Risks in Today’s Digital-Centric World

There are many analytics approaches that use anonymized datasets to combine health and digital data. This whitepaper will provide a summary of regulatory and industry guidance and an overview of current analytics approaches, along with each one’s relative re-identification risk.

Download

Crossix POV: the NAI and Ad Delivering and Reporting

The 2020 Network Advertising Initiative (NAI) Code of Conduct includes updated guidelines for the use of data for Digital Ad Delivery and Reporting (“ADR”). This POV provides a brief summary of the guidelines, as it applies to the measurement of health marketing.

Download

Crossix POV: Web Cookies and Digital Measurement

In the past year, companies that operate major web browsers have introduced or updated existing policies on the use of cookies. This POV provides an overview of how those changes may impact the measurement of digital marketing campaigns.

Download

Crossix is committed to meeting key regulatory and self-regulatory requirements
and protecting reasonable expectations of privacy.

HITRUST CSF Certified status demonstrates that the Crossix data storage, corporate infrastructure, automation systems, Crossix SafeMine™ and Crossix DIFA™ have met key regulatory and industry-defined requirements and are appropriately managing risk.

This achievement places Crossix in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF provides a comprehensive and flexible framework of prescriptive and scalable security controls.

NEWS & EVENTS

NAI Panel: Health-Related Targeting: Helping Consumers, Invading Privacy, or Both?

Crossix CEO & Co-founder Asaf Evenhaim, joined Lauren Dubick, Director, US Data Privacy Counsel, Novartis; Kellyn Bergstrand, Associate Corporate Counsel, PulsePoint; and Meredith Halama, Partner at Perkins Coie LLP, to discuss health-related targeting at the NAI Annual Summit. The panel was moderated by Anthony Matyjaszewski, VP Compliance & Member Development at the Network Advertising Initiative (NAI).

Ready to take your healthcare marketing to the next level?
Put Crossix to work for you.

Contact Us